# Nephron Sc Inc - Inspection Records

Source: https://www.keypedia.com/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18

> Inspection records and compliance data for Nephron Sc Inc in West Columbia, South Carolina. Access full analysis and detailed observations.

---

## Details

- Name: Nephron Sc Inc
- FEI Number: 3010892830
- City: West Columbia
- State: South Carolina
- Country Name: United States
- Address Line 1: 4500 12th Street Ext
- Zip Code: 29172
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Nephron Sc Inc - 2025-08-22](https://www.keypedia.com/records/483/nephron-sc-inc/138bf3dc-807d-445f-be48-21d4172245a5) — source: FDA, date: August 22, 2025
- [FDA Inspection 1274364 - Nephron Sc Inc - 2025-08-22](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/cbad2da2-21ae-41c8-8520-a2c9826226d4) — source: FDA, date: August 22, 2025
- [FDA Inspection 1247772 - Nephron Sc Inc - 2024-09-25](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/8d6892d9-27b4-4159-a498-fc8bfe4ed24c) — source: FDA, date: September 25, 2024
- [FDA Inspection 1229051 - Nephron Sc Inc - 2024-02-09](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/7610bef4-1d7f-4cb3-bd8f-ee549586e73d) — classification: Official Action Indicated (OAI), source: FDA, date: February 9, 2024
- [FDA Inspection 1197994 - Nephron Sc Inc - 2023-02-10](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/5c6a8c2a-0cd7-4f46-bc21-9f3d518ae97d) — classification: Official Action Indicated (OAI), source: FDA, date: February 10, 2023
- [483 - Nephron Sc Inc - 2022-04-20](https://www.keypedia.com/records/483/nephron-sc-inc/3dd6396e-f65d-40e5-9652-35c68210bbcd) — source: FDA, date: April 20, 2022
- [WARNING_LETTER - Nephron Sc Inc - 2022-04-20](https://www.keypedia.com/records/warning_letter/nephron-sc-inc/fb25266d-0c42-4d39-9684-7eafaa7ba68e) — source: FDA, date: April 20, 2022
- [FDA Inspection 1168119 - Nephron Sc Inc - 2022-04-20](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/dbba7c32-d2ce-4576-b4c6-077bb9144c98) — classification: Official Action Indicated (OAI), source: FDA, date: April 20, 2022
- [WARNING_LETTER - Nephron Sc Inc - 2020-09-22](https://www.keypedia.com/records/warning_letter/nephron-sc-inc/528714ca-cb23-40df-ae69-431984f050f7) — source: FDA, date: September 22, 2020
- [FDA Inspection 927728 - Nephron Sc Inc - 2015-03-12](https://www.keypedia.com/records/fda_inspections/nephron-sc-inc/fd3fd497-9937-457d-a5ca-1ef582e1a236) — classification: No Action Indicated (NAI), source: FDA, date: March 12, 2015

## Related Companies

- [Dendreon Pharmaceuticals LLC](https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/68ccd67e-0a3a-41cb-ae30-e9e10a6eaef5)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)
- [TOLMAR, Inc.](https://www.keypedia.com/companies/tolmar-inc/a73dea00-baea-4f0e-8234-c0becc61322e)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Procter & Gamble Manufactura S. de R.L. de C.V.](https://www.keypedia.com/companies/procter-gamble-manufactura-s-de-rl-de-cv/8b78eeab-6efe-4a8d-b98a-c1bfda966646)
- [Qilu Animal Health Products Co., Ltd.](https://www.keypedia.com/companies/qilu-animal-health-products-co-ltd/8466eb41-9765-42fd-bcb9-1967ddab39db)
- [Celltrion Pharm, Inc.](https://www.keypedia.com/companies/celltrion-pharm-inc/481a4273-bf7e-4b37-8cd8-08b977ba576b)
- [Modavar Pharmaceuticals](https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9)

## Related Officers

- [Director](https://www.keypedia.com/people/robert-dean/6971bf6a-a3ee-42a5-bc4b-e88ad85df505)
- [Brandon C. Heitmeier](https://www.keypedia.com/people/brandon-c-heitmeier/09e1b64b-01de-4f8b-819a-1179d8b4c0c1)
- [Investigator](https://www.keypedia.com/people/demario-l-walls/c69c4c87-f001-45ab-8d7b-b45c60226ff1)
- [Acting Program Division Director](https://www.keypedia.com/people/frances-de-jesus/b07b8929-85a5-4441-adff-74522fd8466a)